Krilogy Financial LLC Iterum Therapeutics PLC Transaction History

Krilogy Financial LLC

  • $1.35 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 14, 2022
BUY
$0.19 - $0.36 $38,000 - $72,000
200,000 New
200,000 $40,000
Q4 2021

Jan 27, 2022
SELL
$0.39 - $0.74 $31,590 - $59,940
-81,000 Closed
0 $0
Q3 2021

Oct 25, 2021
BUY
$0.54 - $2.29 $27,000 - $114,500
50,000 Added 161.29%
81,000 $45,000
Q2 2021

Jul 20, 2021
BUY
$0.97 - $2.39 $30,070 - $74,090
31,000 New
31,000 $72,000

Others Institutions Holding ITRM

# of Institutions
1
Shares Held
66
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $15.9M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track Krilogy Financial LLC Portfolio

Follow Krilogy Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krilogy Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email